Merrimack Pharmaceuticals Inc (MACK:NASDAQ) Investor Relations Material

Overview

Cambridge, Massachusetts-based biopharmaceutical firm, Merrimack Pharmaceuticals, Inc., has been in operation since 1993. As a player in the industry, the company is primarily involved in the development and commercialization of medicines.

Annual Reports

Frequently Asked Questions

What is Merrimack Pharmaceuticals Inc's ticker?

Merrimack Pharmaceuticals Inc's ticker is MACK

What exchange is Merrimack Pharmaceuticals Inc traded on?

The company's shares trade on the NASDAQ stock exchange

Where are Merrimack Pharmaceuticals Inc's headquarters?

They are based in Cambridge, Massachusetts

How many employees does Merrimack Pharmaceuticals Inc have?

There are 201-500 employees working at Merrimack Pharmaceuticals Inc

What is Merrimack Pharmaceuticals Inc's website?

It is http://www.merrimackpharma.com/

What type of sector is Merrimack Pharmaceuticals Inc?

Merrimack Pharmaceuticals Inc is in the Healthcare sector

What type of industry is Merrimack Pharmaceuticals Inc?

Merrimack Pharmaceuticals Inc is in the Biotechnology industry

Who are Merrimack Pharmaceuticals Inc's peers and competitors?

The following five companies are Merrimack Pharmaceuticals Inc's industry peers:

- IntelliPharmaCeutics International Inc.

- Allogene Therapeutics

- HUTCHMED (China)

- Atreca, Inc.

- Mustang Bio, Inc.